NCT00005086View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

August 31, 2002

Study Completion Date

April 30, 2005

Conditions
Bladder Cancer
Interventions
DRUG

cisplatin

DRUG

docetaxel

DRUG

gemcitabine hydrochloride

DRUG

methotrexate

Trial Locations (4)

60640

Louis A. Weiss Memorial Hospital, Chicago

61602

Oncology/Hematology Associates of Central Illinois, P.C., Peoria

60637-1470

University of Chicago Cancer Research Center, Chicago

46885-5099

Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Chicago

OTHER

NCT00005086 - Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer | Biotech Hunter | Biotech Hunter